by Anne-Fleur | Oct 28, 2022 | Publications
Optimal imaging time points considering accuracy and precision of Patlak linearization for 89Zr-immuno-PET: a simulation study ABSTRACT Purpose Zirconium-89-immuno-positron emission tomography (89Zr-immuno-PET) has enabled visualization of zirconium-89 labelled...
by Anne-Fleur | Oct 1, 2022 | Publications
Radiomic Signatures Associated with CD8+ Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study ABSTRACT Simple Summary: Immune checkpoint inhibitors can be effective drugs to treat cancer. However, only a minority of patients derive...
by Janneke de Haan | Jun 6, 2022 | Publications
Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica ABSTRACT Introduction Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two interrelated inflammatory diseases...
by Janneke de Haan | Apr 23, 2022 | Publications
Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD81 T cells in giant cell arteritis ABSTRACT Objectives Evidence from temporal artery tissue and blood suggests involvement of CD8þ T cells in the pathogenesis of GCA,...
by Janneke de Haan | Apr 23, 2022 | Publications
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy ABSTRACT Introduction Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and molecular imaging (MI), including positron emission tomography (PET),...
by Janneke de Haan | Dec 22, 2021 | Publications
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy ABSTRACT Introduction Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and molecular imaging (MI), including positron emission tomography (PET), single-photon...
Recent Comments